A recent study has found a possible connection between a common type of blood pressure medication, called calcium channel blockers (CCBs), and a higher risk of glaucoma. Glaucoma is a serious eye disease that can lead to blindness if it’s not treated early.
This discovery has raised concerns for millions of people who rely on these medications to manage their blood pressure.
The research was led by Dr. Alan Kastner and his team at Moorfields Eye Hospital and University College London. They looked at the medical records of over 427,000 adults in the UK, including 33,175 people who were taking CCBs.
Even after considering other factors like age, lifestyle habits, and existing health problems, the study found that those taking CCBs were more likely to be diagnosed with glaucoma.
This is significant because glaucoma often doesn’t show symptoms in its early stages. Most people don’t realize they have it until the disease has already caused vision loss. Typically, glaucoma is linked to high pressure inside the eye, which can damage the optic nerve.
However, this study suggests that CCBs might increase the risk of glaucoma through a different, as-yet-unknown process. Surprisingly, some people in the study developed early signs of glaucoma even when their eye pressure was normal.
Calcium channel blockers are widely used to treat high blood pressure. They work by relaxing the blood vessels, which helps improve blood flow and lowers pressure in the arteries.
But the study’s findings suggest that the effects of CCBs on the body might be more complicated than previously thought. This highlights how medications can sometimes have unintended effects on other parts of the body, including the eyes.
If you take CCBs, this doesn’t mean you should stop your medication. Managing high blood pressure is very important for your overall health, as uncontrolled blood pressure can lead to serious problems like heart attacks and strokes.
However, the study suggests it’s a good idea to discuss these findings with your doctor. Together, you can weigh the benefits of the medication against its potential risks and explore other options if necessary.
Glaucoma is often called the “silent thief of sight” because it develops gradually and without pain. By the time symptoms appear, significant damage to the optic nerve may have already occurred.
Regular eye exams are crucial for catching glaucoma early, especially for people at higher risk, such as those with a family history of the disease, older adults, and now, possibly, people taking CCBs.
Dr. Kastner and his team have emphasized that more research is needed to understand how CCBs might be linked to glaucoma. This study provides important information, but it also raises new questions. For example, researchers still don’t know exactly how CCBs might contribute to changes in the eyes or whether some people are more vulnerable to these effects than others.
The findings were published in the medical journal JAMA Ophthalmology and serve as a reminder to stay informed about the medications you’re taking. Regular communication with your healthcare providers is key.
If you’re concerned about your eye health, schedule a check-up with an eye doctor. They can check for early signs of glaucoma and help you take steps to protect your vision.
While these findings might sound alarming, they are also an opportunity to be proactive about your health. By keeping up with regular doctor visits, asking questions about your medications, and prioritizing routine eye exams, you can protect both your heart and your eyesight.
If you care about blood pressure, please read studies about how diets could help lower high blood pressure, and 3 grams of omega-3s a day keep high blood pressure at bay.
For more information about blood pressure,, please see recent studies that beetroot juice could help reduce blood pressure, and results showing cinnamon could help lower high blood pressure.
Copyright © 2025 Knowridge Science Report. All rights reserved.
